Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Poly(rC)-binding protein 1 (PCBP1) is a multifunctional RNA-binding protein involved in the regulation of mRNA splicing, stabilization, and translation, as well as cytosolic iron chaperone activity essential for safe iron delivery and storage[1][2][3]. PCBP1, along with other PCBP family members, contains three conserved KH domains that enable sequence-specific RNA and DNA binding, especially to C-rich regions[1][2]. PCBP1 plays key roles in tumor suppression, including regulation of alternative splicing of genes involved in cancer cell invasion and metastasis[5]. In the nervous system, it modulates processes implicated in neurodegeneration, such as neuroinflammation and protein ubiquitination[4]. PCBP1 is considered a potential therapeutic target in cancer, neurodegenerative diseases, and iron-related metabolic disorders, but no clinically approved drugs directly target this molecule as of the latest reports[2][5][6].
No drugs directly targeting PCBP1 are recorded in primary databases or literature as of August 2025; mechanism is based on modulation of RNA stability, splicing, and delivery of iron to ferritin and other iron-dependent enzymes[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Poly(rC)-binding protein 1 (PCBP1).